|
1
|
Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R,
Davies NA, Cooper CE, Singer M. Association between mitochondrial
dysfunction and severity and outcome of septic shock. Lancet 2002; 360:
219-23.
|
|
2
|
O'Brien AJ, Clapp L, Singer M. Terlipressin therapy for norepinephrine-resistant septic shock. Lancet 2002; 359: 1209-10.
|
|
3
|
Brealey
D, Karyampudi S, Jacques T, Noveilli M, Stidwill R, Taylor V, Smolenski
R, Singer M. Mitochondrial dysfunction in a long-term model of sepsis
and organ failure. Am J Physiol Regul Integr Comp Physiol. 2004; 286:
R491-7
|
|
4
|
Singer M, De Santis V, Vitale D, Jeffcoate
W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic
response to overwhelming systemic inflammation. Lancet 2004; 364:545-8.
|
|
5
|
McKendry
M, McGloin H, Saberi D, Caudwell L, Brady AR, Singer M. Randomised
controlled trial assessing the impact of a nurse delivered, flow
monitored protocol for optimisation of circulatory status after cardiac
surgery. BMJ 2004; 329:258
|
6
|
Cepeda JA, Whitehouse T, Cooper B, Hails
J, Jones K, Kwaku F, Taylor L, Hayman S, Cookson B, Shaw S, Kibbler C,
Singer M, Bellingan G, Wilson APR. Isolation of patients in single
rooms or cohorts to reduce spread of MRSA in intensive-care units:
prospective two-centre study. Lancet 2005
|
